| __timestamp | Supernus Pharmaceuticals, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72471000 | 1499100000 |
| Thursday, January 1, 2015 | 89204000 | 1923500000 |
| Friday, January 1, 2016 | 106010000 | 2351400000 |
| Sunday, January 1, 2017 | 137905000 | 2564000000 |
| Monday, January 1, 2018 | 159888000 | 2397300000 |
| Tuesday, January 1, 2019 | 158425000 | 2503400000 |
| Wednesday, January 1, 2020 | 200677000 | 3344600000 |
| Friday, January 1, 2021 | 304759000 | 4529200000 |
| Saturday, January 1, 2022 | 377221000 | 4179100000 |
| Sunday, January 1, 2023 | 336361000 | 4650100000 |
Data in motion
In the ever-evolving pharmaceutical landscape, effective cost management is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Viatris Inc. and Supernus Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Viatris Inc. consistently outpaced Supernus Pharmaceuticals in SG&A spending, with a peak in 2023 reaching approximately $4.65 billion, marking a 210% increase from 2014. In contrast, Supernus Pharmaceuticals saw a more modest rise, with expenses growing by 364% over the same period, peaking at around $377 million in 2022. This disparity highlights Viatris's expansive operational scale compared to Supernus's more focused approach. Understanding these trends provides valuable insights into each company's strategic priorities and market positioning, offering a window into their financial health and future trajectories.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Zoetis Inc. vs Viatris Inc.
Who Optimizes SG&A Costs Better? Biogen Inc. or Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Viatris Inc. and Halozyme Therapeutics, Inc.
Selling, General, and Administrative Costs: Viatris Inc. vs Ultragenyx Pharmaceutical Inc.
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Viatris Inc. and Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Supernus Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.